Liu, D. (2019). CAR-T "the living drugs", immune checkpoint inhibitors, and precision medicine: A new era of cancer therapy. Journal of Hematology & Oncology, 12(1), N.PAG. https://doi.org/10.1186/s13045-019-0819-1
Chicago Style (17th ed.) CitationLiu, Delong. "CAR-T "the Living Drugs", Immune Checkpoint Inhibitors, and Precision Medicine: A New Era of Cancer Therapy." Journal of Hematology & Oncology 12, no. 1 (2019): N.PAG. https://doi.org/10.1186/s13045-019-0819-1.
MLA (9th ed.) CitationLiu, Delong. "CAR-T "the Living Drugs", Immune Checkpoint Inhibitors, and Precision Medicine: A New Era of Cancer Therapy." Journal of Hematology & Oncology, vol. 12, no. 1, 2019, p. N.PAG, https://doi.org/10.1186/s13045-019-0819-1.
Warning: These citations may not always be 100% accurate.